Close Menu

NEW YORK (360Dx) – Inova Diagnostics today said that the US Food and Drug Administration has cleared the firm's Quanta Flash Rheumatoid Factor IgM and Quanta Flash RF IgA assays.

The two chemiluminescent immunoassays are for use in human sera and are indicated for the quantitative determination of IgM RF antibodies and the semi-quantitative determination of IgA RF antibodies. The presence of the antibodies, along with clinical findings and other laboratory tests, are used to help diagnose rheumatoid arthritis.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.